Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting

BACKGROUND: Small cell lung cancer (SCLC) represents approximately 13 to 18% of all lung cancers. It is the most aggressive among lung cancers, mostly presented at an advanced stage, with median survival rates of 10 to12 months in patients treated with standard chemotherapy and radiotherapy. In appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lekic, Mirko, Kovac, Viljem, Triller, Nadja, Knez, Lea, Sadikov, Aleksander, Cufer, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423766/
https://www.ncbi.nlm.nih.gov/pubmed/22933980
http://dx.doi.org/10.2478/v10019-012-0007-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423766/
https://www.ncbi.nlm.nih.gov/pubmed/22933980
http://dx.doi.org/10.2478/v10019-012-0007-1

Ejemplares similares